Joel A Sincavage

Array ( [id] => 993371 [patent_doc_number] => 06916470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Methods for use of mpl ligands with primitive human stem cells' [patent_app_type] => utility [patent_app_number] => 10/052879 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 14509 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916470.pdf [firstpage_image] =>[orig_patent_app_number] => 10052879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6558421 [patent_doc_number] => 20020164578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Nucleic acid molecules encoding glutx and uses thereof' [patent_app_type] => new [patent_app_number] => 09/981947 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21136 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164578.pdf [firstpage_image] =>[orig_patent_app_number] => 09981947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 725080 [patent_doc_number] => 07045616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 09/964666 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 45 [patent_no_of_words] => 16335 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045616.pdf [firstpage_image] =>[orig_patent_app_number] => 09964666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6689895 [patent_doc_number] => 20030033621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 09/964667 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16470 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20030033621.pdf [firstpage_image] =>[orig_patent_app_number] => 09964667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623672 [patent_doc_number] => 07138380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 09/964412 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 43 [patent_no_of_words] => 16319 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138380.pdf [firstpage_image] =>[orig_patent_app_number] => 09964412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796829 [patent_doc_number] => 20030175703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'RNA aptamers and methods for identifying the same' [patent_app_type] => new [patent_app_number] => 09/963827 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 31645 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175703.pdf [firstpage_image] =>[orig_patent_app_number] => 09963827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697272 [patent_doc_number] => 20030109466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Antisense modulation of KSR expression' [patent_app_type] => new [patent_app_number] => 09/961001 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25005 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109466.pdf [firstpage_image] =>[orig_patent_app_number] => 09961001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082445 [patent_doc_number] => 20020082236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Compositions and methods for activating genes of interest' [patent_app_type] => new [patent_app_number] => 09/956998 [patent_app_country] => US [patent_app_date] => 2001-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6803 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082236.pdf [firstpage_image] =>[orig_patent_app_number] => 09956998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6597759 [patent_doc_number] => 20020042360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Methods and compositions for modulating angiogenesis' [patent_app_type] => new [patent_app_number] => 09/960708 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9441 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042360.pdf [firstpage_image] =>[orig_patent_app_number] => 09960708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278589 [patent_doc_number] => 20020107217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'galK' [patent_app_type] => new [patent_app_number] => 09/953657 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10097 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107217.pdf [firstpage_image] =>[orig_patent_app_number] => 09953657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6278592 [patent_doc_number] => 20020107218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Inhibition of stress activated protein kinase (SAPK) pathway and sensitization of cells to cancer therapies' [patent_app_type] => new [patent_app_number] => 09/955406 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10364 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20020107218.pdf [firstpage_image] =>[orig_patent_app_number] => 09955406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5908074 [patent_doc_number] => 20020142982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Method for regulating angiogenesis' [patent_app_type] => new [patent_app_number] => 09/945353 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17324 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142982.pdf [firstpage_image] =>[orig_patent_app_number] => 09945353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6014956 [patent_doc_number] => 20020102245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => '14-3-3sigma arrests the cell cycle' [patent_app_type] => new [patent_app_number] => 09/939581 [patent_app_country] => US [patent_app_date] => 2001-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14755 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102245.pdf [firstpage_image] =>[orig_patent_app_number] => 09939581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720666 [patent_doc_number] => 20030054354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Use of antisense oligonucleotide libraries for identifying gene function' [patent_app_type] => new [patent_app_number] => 09/938048 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 29667 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054354.pdf [firstpage_image] =>[orig_patent_app_number] => 09938048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847423 [patent_doc_number] => 20030166590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Microsomal triglyceride transfer protein' [patent_app_type] => new [patent_app_number] => 09/933593 [patent_app_country] => US [patent_app_date] => 2001-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 42748 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166590.pdf [firstpage_image] =>[orig_patent_app_number] => 09933593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439115 [patent_doc_number] => 20020128219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Novel molecules of the card related protein family and uses thereof' [patent_app_type] => new [patent_app_number] => 09/931071 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 35627 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128219.pdf [firstpage_image] =>[orig_patent_app_number] => 09931071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783498 [patent_doc_number] => 20030064946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Method and reagent for the inhibition of calcium activated chloride channel-1 (CLCA-1)' [patent_app_type] => new [patent_app_number] => 09/927046 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 57273 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064946.pdf [firstpage_image] =>[orig_patent_app_number] => 09927046 [rel_patent_id] =>[rel_patent_doc_number] =>)